Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Inspections, Compliance, Enforcement, and Criminal Investigations

  • Print
  • Share
  • E-mail
-

Center for Drug Evaluation and Research (CDER) 2001

Chapter 3

Center for Drug Evaluation and Research

 

Table of Contents
  
The various reports found under each of the following headings are only a selection of those occurring during the fiscal year and are not all inclusive. This publication does not encompass all of the activities taken by the FDA to bring about compliance.

Bioresearch Monitoring Program

Good Manufacturing Program

Active Pharmaceutical Ingredients

Manufacturers of Finsihed Pharmaceuticals

Medical Gases

Repackers

Prescription Drug Distribution Facility

Internet Enforcement Activities

Over-the-Counter Drugs

Postmaketing Adverse Drug Experience Reports

Unapproved Drugs

Charts

CDER Enforcement Actions FY 1997-2001

CDER Surveillance Activity FY 1997-2001

CDER Inspections FY 1997-2001

CDER Foreign Inspections FY 1997-2001

CDER Recalls FY 1997-2001

 
-
-